0001213900-23-000317.txt : 20230103 0001213900-23-000317.hdr.sgml : 20230103 20230103150209 ACCESSION NUMBER: 0001213900-23-000317 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230101 FILED AS OF DATE: 20230103 DATE AS OF CHANGE: 20230103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mark Elad CENTRAL INDEX KEY: 0001960205 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37353 FILM NUMBER: 23501732 MAIL ADDRESS: STREET 1: 27 HAILANOT CITY: HERZLIYA STATE: L3 ZIP: 4631214 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BiondVax Pharmaceuticals Ltd. CENTRAL INDEX KEY: 0001611747 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: JERUSALEM BIOPARK, 2ND FLOOR STREET 2: HADASSAH EIN KEREM CAMPUS CITY: JERUSALEM STATE: L3 ZIP: 00000 BUSINESS PHONE: 972-8-9302529 MAIL ADDRESS: STREET 1: JERUSALEM BIOPARK, 2ND FLOOR STREET 2: HADASSAH EIN KEREM CAMPUS CITY: JERUSALEM STATE: L3 ZIP: 00000 3 1 ownership.xml X0206 3 2023-01-01 0 0001611747 BiondVax Pharmaceuticals Ltd. BVXV 0001960205 Mark Elad JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 9112001 ISRAEL 0 1 0 0 Chief Operating Officer Restricted Share Units 2024-10-18 2031-10-16 Ordinary Shares 360000 D Restricted Share Units 2025-03-23 2032-03-23 Ordinary Shares 1412000 D The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents four hundred Ordinary Shares. Each restricted share unit represents a contingent right to receive one ordinary share. /s/ Elad Mark 2023-01-03